Nephro Care India Ltd
NSE: NEPHROCARE
₹68.00
₹0.15
(0.22%)
As on 22-Jun-2026IST
Market cap
₹112 Cr
Revenue (TTM)
₹46 Cr
P/E Ratio
33.3
P/B Ratio
2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4 Cr
-
ROE
10.6 %
-
ROCE
14.4 %
-
Industry P/E
52.13
-
EV/EBITDA
10.7
-
Debt to Equity
0
-
Book Value
₹32.4
-
EPS
₹2.2
-
Face value
10
-
Shares outstanding
16,486,400
5 Years Aggregate
CFO
₹13.70 Cr
EBITDA
₹16.04 Cr
Net Profit
₹10.59 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nephro Care India
| -38.5 | -15.9 | 7.0 | -45.2 | -- | -- | -- |
|
BSE Healthcare
| 11.1 | 0.8 | 14.0 | 11.9 | 24.3 | 14.1 | 12.5 |
|
Company
|
2025
|
|---|---|
|
Nephro Care India
| -42.6 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nephro Care India
|
68.0 | 112.1 | 46.0 | 3.6 | -- | 10.6 | 33.3 | 2.0 |
| 268.4 | 4,252.1 | 1,081.2 | 103.7 | 13.0 | 11.7 | 41 | 4.9 | |
| 789.9 | 40,931.6 | 4,643.2 | 464.1 | 13.7 | 8.9 | 105.5 | 8.9 | |
| 472.3 | 14,942.6 | 2,080.1 | 168.1 | 14.1 | 6.7 | 112.2 | 7.4 | |
| 615.4 | 9,179.9 | 2,545.4 | 21.3 | 8.7 | 11.4 | 667.1 | 6.9 | |
| 1,357.5 | 8,899.6 | 1,499.8 | 194.2 | 17.1 | 13.2 | 45.9 | 5.8 | |
| 5,842.5 | 6,390.9 | 1,586.5 | 244.5 | 20.8 | 19.5 | 26.1 | 4.8 | |
| 289.3 | 12,472.0 | 1,393.6 | 213.2 | -- | 22.1 | 48.3 | 5.9 | |
| 1,446.8 | 14,675.8 | 1,703.1 | 281.5 | 23.1 | 17.7 | 52.7 | 8.9 | |
| 851.9 | 8,213.3 | 1,199.2 | 171.1 | 16.3 | 10.2 | 46.8 | 4.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Nephro Care India
--
-
Incorporated
2014
-
Chairman
--
-
Managing Director
Pratim Sengupta
-
Headquarters
24 Parganas (North), West Bengal
-
Website
Looking for more details about Nephro Care India Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Nephro Care India
What is the current share price of Nephro Care India Ltd Today?
The share price of Nephro Care India Ltd is ₹68.00 (NSE) as of 22-Jun-2026 IST. Nephro Care India Ltd has given a return of -45.25% in the last 1 years.
What is the current PB & PE ratio of Nephro Care India Ltd?
The P/E ratio of Nephro Care India Ltd is 33.28 times as on 22-Jun-2026, a 36 discount to its peers’ median range of 52.13 times.
The P/B ratio of Nephro Care India Ltd is 1.97 times as on 22-Jun-2026, a 71 discount to its peers’ median range of 6.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
57.61
|
3.92
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Nephro Care India Ltd?
The 52-week high and low of Nephro Care India Ltd are Rs 183.00 and Rs 50.05 as of 23-Jun-2026.
What is the market cap of Nephro Care India Ltd?
Nephro Care India Ltd has a market capitalisation of ₹ 112 Cr as on 22-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Nephro Care India Ltd?
Before investing in Nephro Care India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.